MOMs program to reduce severe pregnancy and delivery complications
Maternal OutcoMes (MOMs) Program: Testing Integrated Maternal Care Model Approaches to Reduce Risk of Severe Maternal Morbidity
['FUNDING_R01'] · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · NIH-11120895
This project is trying two levels of integrated prenatal and postnatal care to help Black and Hispanic pregnant people at higher risk of severe childbirth complications.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (nih funded) |
| Locations | 1 site (MANHASSET, UNITED STATES) |
| Trial ID | NIH-11120895 on ClinicalTrials.gov |
What this research studies
You would be offered the MOMs integrated care model beginning during pregnancy and continuing after delivery. Participants are randomly assigned to one of two levels of support—either more intensive outreach and care coordination or a lighter-touch approach—delivered through clinics and digital tools including an AI chat bot. The program focuses on preventing preeclampsia, supporting healthy behaviors like physical activity, and connecting you to social and clinical services. Researchers will follow health outcomes such as severe maternal complications and hospital readmissions to see which approach best reduces risk.
Who could benefit from this research
Good fit: Ideal candidates are Black or Hispanic pregnant people with an Obstetrics-Comorbidity Index score of 2 or higher and/or a history of preeclampsia who receive care at participating clinics.
Not a fit: People with low obstetric risk or those not receiving care at participating sites are unlikely to gain direct benefits from this program.
Why it matters
Potential benefit: If successful, this could reduce the chance of serious complications around childbirth and improve timely follow-up care for higher-risk Black and Hispanic birthing people.
How similar studies have performed: Preliminary data from the MOMs program at Northwell using 2,500 participants showed a 77% reduction in 30‑day SMM-related hospital admissions among Black participants, though extending the program into the prenatal period is a new step.
Where this research is happening
MANHASSET, UNITED STATES
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH — MANHASSET, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FITZPATRICK, STEPHANIE LENAY — FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
- Study coordinator: FITZPATRICK, STEPHANIE LENAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.